Basic Research & Target Identification

Basic Research & Target Identification

Scientists at Southern Research focus on innovative research in the areas of cancer, infectious diseases, and CNS/neurological diseases. With an emphasis on the discovery of new, small-molecule therapeutics and vaccines and generation of intellectual property, our scientists conduct translational science designed to invent small molecules and advance them from the design stage to the clinic. Our drug discovery research staff is comprised of approximately 100 scientists with expertise in medicinal chemistry, molecular biology, biochemistry, and high-throughput screening technologies, all focused on making discoveries that will contribute to improving human health. Our research team and its collaborators also have access to a full set of in-house GLP development services including: toxicology, ADME/PK, animal models, formulations, and bioanalytical sciences.

Research programs include:

Contact Us

For more information about our capabilities, contact us at:
BusDev@SouthernResearch.org
888-322-1166 (U.S.)
1-205-581-2830 (International)